Magnevist

MRI
Treatment
1 FDA approval
16 Active Studies for Magnevist

What is Magnevist

Gadopentetic acidThe Generic name of this drug
Treatment SummaryGadolinium DTPA is a chemical compound used to improve the quality of Magnetic Resonance Imaging (MRI) scans of the brain and spine. This compound is made up of gadolinium and a chelating agent called diethylenetriamine penta-acetic acid (DTPA). It helps doctors get a better image of the patient’s brain and spine during an MRI scan.
Gadopentetate dimeglumineis the brand name
Magnevist Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Gadopentetate dimeglumine
Gadopentetic acid
2014
2

Approved as Treatment by the FDA

Gadopentetic acid, otherwise known as Gadopentetate dimeglumine, is approved by the FDA for 1 uses which include MRI .
MRI

Effectiveness

How Magnevist works in the bodyGadopentetate dimeglumine works by shortening the time it takes for protons to relax in a magnetic field. This allows for better imaging of normal tissues, like the pituitary gland and meninges, that lack a blood-brain barrier. It also helps to detect lesions like neoplasms, abscesses, and subacute infarcts, which have an abnormal vascularity or disrupted blood-brain barrier. Outside of the central nervous system, gadopentetate dimeglumine quickly spreads throughout the interstitial compartment, allowing for better imaging in all tissues. In addition, this compound

When to interrupt dosage

The proposed dosage of Magnevist is contingent on the diagnosed affliction. The quantity of dosage is contingent upon the method of delivery (e.g. Solution or Injection - Intravenous) as outlined in the table below.
Condition
Dosage
Administration
MRI
, 469.01 mg/mL, 469.0 mg/mL
, Intravenous, Injection, Injection - Intravenous, Solution, Solution - Intravenous

Warnings

Magnevist has two counterindications. It should not be combined with any of the conditions stipulated in the table below.Magnevist Contraindications
Condition
Risk Level
Notes
Disease
Do Not Combine
Kidney
Do Not Combine
There are 20 known major drug interactions with Magnevist.
Common Magnevist Drug Interactions
Drug Name
Risk Level
Description
Abacavir
Minor
Gadopentetic acid may decrease the excretion rate of Abacavir which could result in a higher serum level.
Aclidinium
Minor
Gadopentetic acid may decrease the excretion rate of Aclidinium which could result in a higher serum level.
Acrivastine
Minor
Gadopentetic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Albutrepenonacog alfa
Minor
Gadopentetic acid may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
Allylestrenol
Minor
Gadopentetic acid may decrease the excretion rate of Allylestrenol which could result in a higher serum level.

Magnevist Novel Uses: Which Conditions Have a Clinical Trial Featuring Magnevist?

10 active clinical trials are currently being conducted to assess the effectiveness of Magnevist as a contrast agent in Magnetic Resonance Imaging (MRI) scans.
Condition
Clinical Trials
Trial Phases
MRI
16 Actively Recruiting
Phase 2, Not Applicable, Phase 3

Patient Q&A Section about magnevist

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Magnevist a gadolinium?

"The objective of this study was to investigate the gadolinium concentration in blood and urine after the intravenous administration of Magnevist in healthy volunteers.

The purpose of this study was to investigate the gadolinium concentration in blood and urine after the intravenous administration of Magnevist in healthy volunteers in order to better understand the effects of this gadolinium-based contrast agent."

Answered by AI

What is Magnevist used for?

"Magnevist Injection is a medication that is used with magnetic resonance imaging (MRI) to visualize lesions with abnormal vascularity in the brain, spine and associated tissues in adults and children who are at least two years old."

Answered by AI

Is Magnevist discontinued?

"As of 1 February 2018, Omniscan and intravenous Magnevist are now no longer authorized for use and a product recall of any existing unexpired stock is underway. This means that anyone who currently has Omniscan or Magnevist that has not expired must return it to the company."

Answered by AI

What is Magnevist injection?

"Magnevist is a contrast agent that is injected intravenously and is used to improve the quality of MRI images of the brain and spine. It can help to detect abnormalities of the blood vessels or problems with the barrier between the blood and the brain."

Answered by AI

Clinical Trials for Magnevist

Have you considered Magnevist clinical trials? We made a collection of clinical trials featuring Magnevist, we think they might fit your search criteria.
Have you considered Magnevist clinical trials? We made a collection of clinical trials featuring Magnevist, we think they might fit your search criteria.
Have you considered Magnevist clinical trials? We made a collection of clinical trials featuring Magnevist, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top